Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumors: a long-term single institution experience Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002
Clinical experience for diagnosis and surgical treatment primary lung and mediastinal hemangiopericytoma Source: Eur Respir J 2003; 22: Suppl. 45, 367s Year: 2003
Thymic neoplasms: clinical presentation, diagnosis and management - A single institution experience Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Pulmonary metastatic ameloblastoma 45 years after primary resection. A case report Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Salvage treatment in patients with recurrent or resistant malignant pleura mesothelioma. A retrospective study from tertiary oncology department Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Surgical management of rare malignant tumours of lungs: lessons learned Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Pulmonary primary adenocarcinoma: Diagnosis, treatment and outcome Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Thoracic synovial sarcoma: management of a rare tumor and prognosis , a report of 8 cases Source: Virtual Congress 2021 – Rare thoracic surgical disease and the chest wall Year: 2021
Patient experiences of home-based rehabilitation during treatment for inoperable lung cancer. Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018
Should patients with lymphangioleiomyomatosis undergo screening for meningioma? Source: Eur Respir J 2004; 24 : 888-889 Year: 2004
COPD and resectable bronchogenic carcinoma: worse quality of life after surgery? Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006
A randomised trial of active symptom control (ASC) with or without chemotherapy (CT) in the treatment of patients with malignant pleural mesothelioma. First results of the Medical Research Council/British Thoracic Society MS01 trial Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Pulmonary hydatid disease of the childhood: characteristics and a comparison of medical versus surgical treatment Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003
Cushing’s syndrome as a first sign of lung carcinoid in radically operated patient- case report. Source: International Congress 2017 – General thoracic surgery Year: 2017
Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment? Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Our clinical experience in surgical therapy of patients with bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 344s Year: 2002
Long-term outcome of extrapleural pneumothorax treatment of a patient with pulmonary TB – a case report which brings us back in time Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007
Malignant mesothelioma and chemotherapy: efficacy and influence on survival of patients Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy – Preliminary report Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012